Literature DB >> 18684212

Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome.

L Chang1, S Sundaresh, J Elliott, P A Anton, P Baldi, A Licudine, M Mayer, T Vuong, M Hirano, B D Naliboff, V Z Ameen, E A Mayer.   

Abstract

Enhanced stress responsiveness has been implicated as a potential mechanism contributing to the pathophysiology of irritable bowel syndrome (IBS), and should be reflected in altered function of the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system. Both of these systems can modulate mucosal immune function. The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (ACTH) and cortisol in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and noradrenaline responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS. Two separate studies were conducted in women. In Study 1, basal cortisol levels were analysed in 41 IBS and 25 controls using 24-h collections of plasma ACTH and cortisol (q10 min sampling). In Study 2, 10 IBS patients with diarrhoea (IBS-D) and 10 controls underwent sigmoidoscopy with measurements of stimulated neuroendocrine responses and cytokine mRNA expression in colonic tissue. Basal ACTH levels were significantly blunted (P < 0.05), while basal and stimulated plasma cortisol levels were higher in patients. Basal cortisol levels prior to an experimental visceral stressor positively correlated with anxiety symptoms (P < 0.004), but not IBS symptoms. Irritable bowel syndrome patients with diarrhoea had significantly decreased mRNA expression of mucosal cytokines [interleukin (IL)-2, IL-6] in the sigmoid colon vs controls (P < 0.05). Although dysregulations in stress-responsive systems such as the HPA axis and mucosal immune function are demonstrated in IBS, they do not appear to have a primary role in modulating IBS severity and abdominal pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684212      PMCID: PMC2745840          DOI: 10.1111/j.1365-2982.2008.01171.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  46 in total

1.  Circadian rhythms of women with fibromyalgia.

Authors:  E B Klerman; D L Goldenberg; E N Brown; A M Maliszewski; G K Adler
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

2.  Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses.

Authors:  S Elsenbruch; W C Orr
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

3.  Autonomic nervous system function in women with irritable bowel syndrome.

Authors:  M Heitkemper; M Jarrett; K C Cain; R Burr; R L Levy; A Feld; V Hertig
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

4.  Psychological and physiological responses to postprandial mental stress in women with the irritable bowel syndrome.

Authors:  S Elsenbruch; W R Lovallo; W C Orr
Journal:  Psychosom Med       Date:  2001 Sep-Oct       Impact factor: 4.312

5.  Twenty-four-hour ACTH and cortisol pulsatility in depressed women.

Authors:  E A Young; N E Carlson; M B Brown
Journal:  Neuropsychopharmacology       Date:  2001-08       Impact factor: 7.853

6.  Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood.

Authors:  C Heim; D J Newport; S Heit; Y P Graham; M Wilcox; R Bonsall; A H Miller; C B Nemeroff
Journal:  JAMA       Date:  2000-08-02       Impact factor: 56.272

Review 7.  The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.

Authors:  I J Elenkov; R L Wilder; G P Chrousos; E S Vizi
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

8.  Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications.

Authors:  A D Sperber; Y Atzmon; L Neumann; I Weisberg; Y Shalit; M Abu-Shakrah; A Fich; D Buskila
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

9.  Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse.

Authors:  C Heim; D J Newport; R Bonsall; A H Miller; C B Nemeroff
Journal:  Am J Psychiatry       Date:  2001-04       Impact factor: 18.112

10.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

View more
  85 in total

1.  Immune mediated disorders in women with a fragile X expansion and FXTAS.

Authors:  Isha Jalnapurkar; Nuva Rafika; Flora Tassone; Randi Hagerman
Journal:  Am J Med Genet A       Date:  2014-11-14       Impact factor: 2.802

2.  Association between early adverse life events and irritable bowel syndrome.

Authors:  Kara Bradford; Wendy Shih; Elizabeth J Videlock; Angela P Presson; Bruce D Naliboff; Emeran A Mayer; Lin Chang
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-16       Impact factor: 11.382

3.  Importance of trauma-related fear in patients with irritable bowel syndrome and early adverse life events.

Authors:  Harman Rahal; Elizabeth J Videlock; Adriane Icenhour; Wendy Shih; Bruce Naliboff; Arpana Gupta; Emeran A Mayer; Lin Chang
Journal:  Neurogastroenterol Motil       Date:  2020-06-17       Impact factor: 3.598

Review 4.  Targeting epigenetic mechanisms for chronic visceral pain: A valid approach for the development of novel therapeutics.

Authors:  Tijs Louwies; Casey O Ligon; Anthony C Johnson; Beverley Greenwood-Van Meerveld
Journal:  Neurogastroenterol Motil       Date:  2018-11-04       Impact factor: 3.598

5.  Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes.

Authors:  Anthe S Sterkenburg; Anika Hoffmann; Ursel Gebhardt; Monika Warmuth-Metz; Anna M M Daubenbüchel; Hermann L Müller
Journal:  Neuro Oncol       Date:  2015-04-02       Impact factor: 12.300

6.  Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome.

Authors:  Kristen R Weaver; Gail D'Eramo Melkus; Jason Fletcher; Wendy A Henderson
Journal:  Biol Res Nurs       Date:  2018-02-05       Impact factor: 2.522

7.  Immune activation and gut microbes in irritable bowel syndrome.

Authors:  Khaldun Al-Khatib; Henry C Lin
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

8.  Vaginal hypersensitivity and hypothalamic-pituitary-adrenal axis dysfunction as a result of neonatal maternal separation in female mice.

Authors:  A N Pierce; J M Ryals; R Wang; J A Christianson
Journal:  Neuroscience       Date:  2014-01-23       Impact factor: 3.590

9.  Conditioned pain modulation in women with irritable bowel syndrome.

Authors:  Monica E Jarrett; Robert J Shulman; Kevin C Cain; Wimon Deechakawan; Lynne T Smith; Philippe Richebé; Margaret Eugenio; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2014-01-24       Impact factor: 2.522

10.  Immune-mediated disorders among women carriers of fragile X premutation alleles.

Authors:  Tri Indah Winarni; Weerasak Chonchaiya; Tanjung Ayu Sumekar; Paul Ashwood; Guadalupe Mendoza Morales; Flora Tassone; Danh V Nguyen; Sultana M H Faradz; Judy Van de Water; Kylee Cook; Alyssa Hamlin; Yi Mu; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2012-08-17       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.